Volume 38 Issue 6
Jun.  2022
Turn off MathJax
Article Contents
WANG Zhe, SUN Bo, REN Ping, HUANG Xi. Meranzin Hydrate Effects Atherosclerosis and Depressive Comorbidity in ApoE-/- Rats by Antidyslipidemic, Anti-Inflammatory and Regulate Intestinal Flora[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(6): 511-519. doi: 10.14148/j.issn.1672-0482.2022.0511
Citation: WANG Zhe, SUN Bo, REN Ping, HUANG Xi. Meranzin Hydrate Effects Atherosclerosis and Depressive Comorbidity in ApoE-/- Rats by Antidyslipidemic, Anti-Inflammatory and Regulate Intestinal Flora[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(6): 511-519. doi: 10.14148/j.issn.1672-0482.2022.0511

Meranzin Hydrate Effects Atherosclerosis and Depressive Comorbidity in ApoE-/- Rats by Antidyslipidemic, Anti-Inflammatory and Regulate Intestinal Flora

doi: 10.14148/j.issn.1672-0482.2022.0511
  • Received Date: 2022-03-07
    Available Online: 2022-06-07
  •   OBJECTIVE  Focus on the efficacy of Meranzin hydrate (MH) in the treatment of comorbid AS and depression, and dicuss the mechanism of MH.  METHODS  Sprague Dawley rats with chow diets were elected as the control group, and ApoE-/- rats were fed high-fat diets for 12 weeks to establish the AS multimorbidity with depression model. ApoE-/- rats were randomly divided into the model group and intervention groups (MH 3.5 mg·kg-1, MH 7 mg·kg-1, and simvastatin 7 mg·kg-1 groups). n=6, for each group.  RESULTS  Treatment of comorbid AS and depression with MH could significantly decrease lipid levels, plaque areas, plasma level of inflammatory factors and hippocampus inflammatory cytokines, particularly tumor necrosis factor-α, interleukin(IL)-1β, and IL-6. MH could also improve hippocampal 5-hydroxytryptamine levels as well as depressive-like behavior and regulate intestinal flora.  CONCLUSION  This study demonstrates that MH reduces the inflammatory response as well as lipid levels and improves the composition of intestinal flora, which plays an important role against AS multimorbidity with depression.

     

  • loading
  • [1]
    LIBBY P. The changing landscape of atherosclerosis[J]. Nature, 2021, 592(7855): 524-533. doi: 10.1038/s41586-021-03392-8
    [2]
    CREA F. The growing complexity of the number one killer: Ischaemic heart disease[J]. Eur Heart J, 2021, 42(26): 2513-2517. doi: 10.1093/eurheartj/ehab414
    [3]
    TINETTI ME, FRIED TR, BOYD CM. Designing health care for the most common chronic condition-multimorbidity[J]. JAMA, 2012, 307(23): 1-12.
    [4]
    LANG DM. Multimorbidity: The new normal[J]. Ann Am Thorac Soc, 2013, 10(5): 491-493. doi: 10.1513/AnnalsATS.201308-264ED
    [5]
    WHITTY CJM, WATT FM. Map clusters of diseases to tackle multimorbidity[J]. Nature, 2020, 579(7800): 494-496. doi: 10.1038/d41586-020-00837-4
    [6]
    TULLY PJ, BAUMEISTER H. Collaborative care for the treatment of comorbid depression and coronary heart disease: A systematic review and meta-analysis protocol[J]. Syst Rev, 2014, 3: 127. doi: 10.1186/2046-4053-3-127
    [7]
    DE VRIES HE, KUIPER J, DE BOER AG, et al. The blood-brain barrier in neuroinflammatory diseases[J]. Pharmacol Rev, 1997, 49(2): 143-155.
    [8]
    TANG WHW, WANG ZN, LEVISON BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk[J]. N Engl J Med, 2013, 368(17): 1575-1584. doi: 10.1056/NEJMoa1109400
    [9]
    GANZ T. Antimicrobial polypeptides in host defense of the respiratory tract[J]. J Clin Invest, 2002, 109(6): 693-697. doi: 10.1172/JCI0215218
    [10]
    ROMANO KA, VIVAS EI, AMADOR-NOGUEZ D, et al. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide[J]. mBio, 2015, 6(2): e02481.
    [11]
    ZHANG Y, HUANG RR, CHENG MJ, et al. Gut microbiota from NLRP3-deficient mice ameliorates depressive-like behaviors by regulating astrocyte dysfunction via circHIPK2[J]. Microbiome, 2019, 7: 116. doi: 10.1186/s40168-019-0733-3
    [12]
    TILG H, ZMORA N, ADOLPH TE, et al. The intestinal microbiota fuelling metabolic inflammation[J]. Nat Rev Immunol, 2020, 20(1): 40-54. doi: 10.1038/s41577-019-0198-4
    [13]
    ADHIKARI-DEVKOTA A, KURAUCHI Y, YAMADA T, et al. Anti-neuroinflammatory activities of extract and polymethoxyflavonoids from immature fruit peels of Citrus "Hebesu"[J]. J Food Biochem, 2019, 43(6): e12813. doi: 10.1111/jfbc.12813
    [14]
    XIE WB, QIU XJ, HUANG X, et al. Comparison between the pharmacokinetics of meranzin hydrate in a rat model of chronic depression and in controls following the oral administration of Chaihu-Shugan-San[J]. Exp Ther Med, 2013, 6(4): 913-918. doi: 10.3892/etm.2013.1229
    [15]
    WANG WB, ZHAO LL, HUANG HY, et al. Development of an ultra-high performance liquid chromatography method for simultaneous determination of six active compounds in Fructus aurantii and rat plasma and its application to a comparative pharmacokinetic study in rats administered with different doses[J]. J Anal Methods Chem, 2018, 2018: 7579136.
    [16]
    SHI SQ, YAN H, CHEN Y, et al. Pharmacokinetic study of precisely representative antidepressant, prokinetic, anti-inflammatory and anti-oxidative compounds from Fructus aurantii and Magnolia Bark[J]. Chem Biol Interact, 2020, 315: 108851. doi: 10.1016/j.cbi.2019.108851
    [17]
    YU XB, ZHANG HN, DAI Y, et al. Simvastatin prevents and ameliorates depressive behaviors via neuroinflammatory regulation in mice[J]. J Affect Disord, 2019, 245: 939-949. doi: 10.1016/j.jad.2018.11.086
    [18]
    LIU YL, WANG WK, CHEN Y, et al. Simultaneous quantification of nine components in the plasma of depressed rats after oral administration of Chaihu-Shugan-San by ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry and its application to pharmacokinetic studies[J]. J Pharm Biomed Anal, 2020, 186: 113310. doi: 10.1016/j.jpba.2020.113310
    [19]
    CHEN SJ, ASAKAWA T, DING SS, et al. Chaihu-Shugan-San administration ameliorates perimenopausal anxiety and depression in rats[J]. PLoS ONE, 2013, 8(8): e72428. doi: 10.1371/journal.pone.0072428
    [20]
    LI HT, LI YH, ZHANG XF, et al. The combination of Aquilaria sinensis (lour. ) gilg and Aucklandia costus falc. volatile oils exerts antidepressant effects in a CUMS-induced rat model by regulating the HPA axis and levels of neurotransmitters[J]. Front Pharmacol, 2021, 11: 614413. doi: 10.3389/fphar.2020.614413
    [21]
    BIELIŃSKI M, LESIEWSKA N, BIELIŃSKA J, et al. Affective temperament in inflammatory bowel diseases: Another brick in the wall of differentiation[J]. PLoS ONE, 2018, 13(11): e0205606. doi: 10.1371/journal.pone.0205606
    [22]
    JIA KK, PAN SM, DING H, et al. Chaihu-shugan san inhibits inflammatory response to improve insulin signaling in liver and prefrontal cortex of CUMS rats with glucose intolerance[J]. Biomed Pharmacother, 2018, 103: 1415-1428. doi: 10.1016/j.biopha.2018.04.171
    [23]
    LIANG Y, ZHANG Y, DENG Y, et al. Chaihu-Shugan-San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway[J]. Evid Based Complement Alternat Med, 2018, 2018: 9390786.
    [24]
    LIU Q, SUN NN, WU ZZ, et al. Chaihu-Shugan-San exerts an antidepressive effect by downregulating miR-124 and releasing inhibition of the MAPK14 and Gria3 signaling pathways[J]. Neural Regen Res, 2018, 13(5): 837-845. doi: 10.4103/1673-5374.232478
    [25]
    QIU J, HU SY, SHI GQ, et al. Changes in regional cerebral blood flow with Chaihu-Shugan-San in the treatment of major depression[J]. Pharmacogn Mag, 2014, 10(40): 503-508. doi: 10.4103/0973-1296.141775
    [26]
    KANG S, LEE S, KIM J, et al. Chronic treatment with combined chemotherapeutic agents affects hippocampal micromorphometry and function in mice, independently of neuroinflammation[J]. Exp Neurobiol, 2018, 27(5): 419-436. doi: 10.5607/en.2018.27.5.419
    [27]
    ZHANG TR, LAROSA A, DI RADDO ME, et al. Negative memory engrams in the Hippocampus enhance the susceptibility to chronic social defeat stress[J]. J Neurosci, 2019, 39(38): 7576-7590. doi: 10.1523/JNEUROSCI.1958-18.2019
    [28]
    AZEVEDO EP, POMERANZ L, CHENG J, et al. A role of Drd2 hippocampal neurons in context-dependent food intake[J]. Neuron, 2019, 102(4): 873-886. doi: 10.1016/j.neuron.2019.03.011
    [29]
    FERRAGUD A, VELÁZQUEZ-SÁNCHEZ C, ABDULLATIF AA, et al. Withdrawal from extended, intermittent access to A highly palatable diet impairs hippocampal memory function and neurogenesis: Effects of memantine[J]. Nutrients, 2020, 12(5): 1520. doi: 10.3390/nu12051520
    [30]
    BAUMGARNER KM, SETTI S, DIAZ C, et al. Diet-induced obesity attenuates cytokine production following an immune challenge[J]. Behav Brain Res, 2014, 267: 33-41. doi: 10.1016/j.bbr.2014.03.017
    [31]
    GUILLEMOT-LEGRIS O, MUCCIOLI GG. Obesity-induced neuroinflammation: Beyond the hypothalamus[J]. Trends Neurosci, 2017, 40(4): 237-253. doi: 10.1016/j.tins.2017.02.005
    [32]
    BROWN JM, HAZEN SL. Microbial modulation of cardiovascular disease[J]. Nat Rev Microbiol, 2018, 16(3): 171-181. doi: 10.1038/nrmicro.2017.149
    [33]
    MA JL, LI HK. The role of gut microbiota in atherosclerosis and hypertension[J]. Front Pharmacol, 2018, 9: 1082. doi: 10.3389/fphar.2018.01082
    [34]
    MAES M, KUBERA M, LEUNIS JC. The gut-brain barrier in major depression: Intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression[J]. Neuro Endocrinol Lett, 2008, 29(1): 117-124.
    [35]
    MAES M, KUBERA M, LEUNIS JC, et al. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes[J]. Acta Psychiatr Scand, 2013, 127(5): 344-354. doi: 10.1111/j.1600-0447.2012.01908.x
    [36]
    DUTTAROY AK. Role of gut microbiota and their metabolites on atherosclerosis, hypertension and human blood platelet function: A review[J]. Nutrients, 2021, 13(1): 144. doi: 10.3390/nu13010144
    [37]
    LIU QF, KIM HM, LIM S, et al. Effect of probiotic administration on gut microbiota and depressive behaviors in mice[J]. DARU J Pharm Sci, 2020, 28(1): 181-189. doi: 10.1007/s40199-020-00329-w
    [38]
    GERSHON MD, TACK J. The serotonin signaling system: From basic understanding to drug development for functional GI disorders[J]. Gastroenterology, 2007, 132(1): 397-414. doi: 10.1053/j.gastro.2006.11.002
    [39]
    SUN QH, LIU ZJ, ZHANG L, et al. Sex-based differences in fecal short-chain fatty acid and gut microbiota in irritable bowel syndrome patients[J]. J Dig Dis, 2021, 22(5): 246-255. doi: 10.1111/1751-2980.12988
    [40]
    LYU M, WANG YF, FAN GW, et al. Balancing herbal medicine and functional food for prevention and treatment of cardiometabolic diseases through modulating gut microbiota[J]. Front Microbiol, 2017, 8: 2146. doi: 10.3389/fmicb.2017.02146
    [41]
    ROOPCHAND DE, CARMODY RN, KUHN P, et al. Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome[J]. Diabetes, 2015, 64(8): 2847-2858. doi: 10.2337/db14-1916
    [42]
    ZHU HZ, LIANG YD, MA QY, et al. Xiaoyaosan improves depressive-like behavior in rats with chronic immobilization stress through modulation of the gut microbiota[J]. Biomed Pharmacother, 2019, 112: 108621. doi: 10.1016/j.biopha.2019.108621
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(6)

    Article Metrics

    Article views (173) PDF downloads(15) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return